2 news · updated just now

GS buys Numantec

2026-10-23

Inflexion Sells Majority Stake in Celnor to Goldman Sachs Alternatives

Private equity firm Inflexion agreed to sell a majority stake in Celnor Group, a food safety and compliance testing firm, to Goldman Sachs Alternatives in a deal valuing the company at €1 billion.

reuters · 2026-10-23 08:04 UTC

2026-07-27

Goldman Sachs Alternatives Acquires Control of Italian Medtech Firm Numantec

Goldman Sachs Alternatives agreed to acquire Italian medtech firm Numantec from White Bridge Investment for approximately €700 million. Numantec manufactures healthcare products and drug-delivery devi

reuters · 2026-07-27 04:47 UTC

GS buys Numantec

Inflexion Sells Majority Stake in Celnor to Goldman Sachs Alternatives

Media coverage (2)

Related topics